145
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Diagnostic Accuracy of Serum Calcitonin Gene-Related Peptide and Apolipoprotein E in Migraine: A Preliminary Study

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , , , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 851-856 | Published online: 12 Mar 2021

References

  • Hoffmann J, Baca SM, Akerman S. Neurovascular mechanisms of migraine and cluster headache. J Cereb Blood Flow Metab. 2019;39(4):573–594. doi:10.1177/0271678X17733655
  • Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev. 2017;97:553–622. doi:10.1152/physrev.00034.2015
  • Olesen J. Headache classification committee of the International Headache Society (IHS) the international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211. doi:10.1177/0333102417738202
  • Gazerani P. Current evidence on potential uses of microRNA biomarkers for migraine: from diagnosis to treatment. Mol Diagn Ther. 2019;23(6):681–694. doi:10.1007/s40291-019-00428-8
  • Han D. Association of serum levels of calcitonin gene-related peptide and cytokines during migraine attacks. Ann Indian Acad Neurol. 2019;22(3):277. doi:10.4103/aian.AIAN_371_18
  • Yuasa N, Nagata E, Fujii N, Ito M, Tsukamoto H, Takizawa S. Serum apolipoprotein E may be a novel biomarker of migraine. PLoS One. 2018;13(1):e0190620. doi:10.1371/journal.pone.0190620
  • Duarte H, Teixeira AL, Rocha NP, Domingues RB. Increased serum levels of adiponectin in migraine. J Neurol Sci. 2014;342(1–2):186–188. doi:10.1016/j.jns.2014.04.035
  • Chai NC, Gelaye B, Tietjen GE, et al. Ictal adipokines are associated with pain severity and treatment response in episodic migraine. Neurol. 2015;84:1409–1418. doi:10.1212/WNL.0000000000001443
  • Boćkowski L, Sobaniec W, Żelazowska-rutkowska B. Proinflammatory plasma cytokines in children with migraine. Pediatr Neurol. 2009;41:17–21. doi:10.1016/j.pediatrneurol.2009.02.001
  • Perini F, D’Andrea G, Galloni E, et al. Plasma cytokine levels in migraineurs and controls. Headache. 2005;45(7):926–931. doi:10.1111/j.1526-4610.2005.05135.x
  • Masruha MR, Lin J, de Souza Vieira DS, et al. Urinary 6‐ sulphatoxymelatonin levels are depressed in chronic migraine and several comorbidities. Headache. 2010;50:413–419. doi:10.1111/j.1526-4610.2009.01547.x
  • Durham PL, Vause CV, Derosier F, McDonald S, Cady R, Martin V. Changes in salivary prostaglandin levels during menstrual migraine with associated dysmenorrhea. Headache. 2010;50(5):844–851. doi:10.1111/j.1526-4610.2010.01657.x
  • Cernuda-Morollón E, Larrosa D, Ramón C, Vega J, Martínez-Camblor P, Pascual J. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Neurology. 2013;81(14):1191–1196. doi:10.1212/WNL.0b013e3182a6cb72
  • Mullin K, Kudrow D, Croop R, et al. Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy. Neurology. 2020;94(20):e2121–e2125. doi:10.1212/WNL.0000000000008944
  • Edvinsson L, Haanes KA, Warfvinge K, Krause DN. CGRP as the target of new migraine therapies—successful translation from bench to clinic. Nat Rev Neurol. 2018;14(6):338–350. doi:10.1038/s41582-018-0003-1
  • Yamazaki Y, Zhao N, Caulfield TR, Liu C, Bu G. Apolipoprotein E and alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol. 2019;15:501–518.
  • Lagging C, Lorentzen E, Stanne TM, et al. Genetics of Ischaemic Stroke Functional Outcome (GISCOME) network and the international stroke genetics consortium. APOE ε4 is associated with younger age at ischemic stroke onset but not with stroke outcome. Neurology. 2019;93:849–853. doi:10.1212/WNL.0000000000008459
  • Merritt VC, Ukueberuwa DM, Arnett PA. Relationship between the apolipoprotein E gene and headache following sports-related concussion. J Clin Exp Neuropsychol. 2016;38:941–949. doi:10.1080/13803395.2016.1177491
  • Miao J, Wang F, Zheng W, Zhuang X. Association of the apolipoprotein E polymorphism with migraine: a meta-analysis. BMC Neurol. 2015;15(1):138. doi:10.1186/s12883-015-0385-2
  • Power and Sample size. Available from: http://powerandsamplesize.com/Calculators/Compare-2-Means/2-Sample-Equality. Accessed November, 2019.
  • Blau JN. Migraine: theories of pathogenesis. Lancet. 1992;339(8803):1202–1207. doi:10.1016/0140-6736(92)91140-4
  • Colton CA, Brown CM, Cook D, et al. APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress. Neurobiol Aging. 2002;23(5):777–785. doi:10.1016/s0197-4580(02)00016-7
  • Pradhan AA, Bertels Z, Akerman S. Targeted nitric oxide synthase inhibitors for migraine. Neurotherapeutics. 2018;15(2):391–401. doi:10.1007/s13311-018-0614-7
  • Gupta R, Kumar V, Luthra K, Banerjee B, Bhatia MS. Polymorphism in apolipoprotein E among migraineurs and tension-type headache subjects. J Headache Pain. 2009;10(2):115‐120. doi:10.1007/s10194-008-0094-y
  • Tvedskov JF, Lipka K, Ashina M, Iversen HK, Schiffter S, Olesen J. No increase of calcitonin-gene related peptide in jugular blood during migraine. Ann Neurol. 2005;58:561–568. doi:10.1002/ana.20605
  • Gallai V, Sarchielli P, Floridi A, et al. Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictaIly and ictally. Cephalalgia. 1995;15:384–390. doi:10.1046/j.1468-29821995.1505384.x
  • Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990;28(2):183–187. doi:10.1002/ana.410280213
  • Affaitati G, Costantini R, Tana C, et al. Co-occurrence of pain syndromes. J Neural Transm. 2020;127(4):625–646.